MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-27-2026
Retractable Technologies Long-Term Debt 2011-2026 | RVP
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Retractable Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 896 K | 900 K | 1.23 M | 1.53 M | 1.81 M | 1.03 M | 2.38 M | 2.64 M | 3.08 M | 3.5 M | 3.42 M | 3.43 M | 3.58 M | 3.83 M | 4.14 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.14 M | 896 K | 2.49 M |
Quarterly Long-Term Debt Retractable Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 624 K | 718 K | 807 K | 900 K | 987 K | 1.07 M | 1.15 M | 1.23 M | 1.31 M | 1.39 M | 1.46 M | 1.53 M | 1.6 M | 1.66 M | 1.74 M | 1.81 M | 1.89 M | 1.96 M | 2.18 M | 2.71 M | 2.71 M | 2.71 M | 2.71 M | 2.38 M | 2.38 M | 2.38 M | 2.38 M | 2.64 M | 2.64 M | 2.64 M | 2.64 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 3.43 M | 3.43 M | 3.43 M | 3.43 M | 3.58 M | 3.58 M | 3.58 M | 3.58 M | 3.83 M | 3.83 M | 3.83 M | 3.83 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.14 M | 624 K | 2.66 M |
Long-Term Debt of other stocks in the Medical instruments industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
2.46 B | $ 70.29 | 0.17 % | $ 14 B |  USA |
 |
Luminex Corporation
LMNX
|
203 M | - | - | $ 1.75 B | USA |
 |
Alcon
ALC
|
3.95 B | $ 74.63 | 0.09 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
24.7 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.05 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
70.6 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.66 B | - | -0.05 % | $ 10.3 B | USA |
 |
Baxter International
BAX
|
9.44 B | $ 16.65 | -0.18 % | $ 8.54 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
288 M | - | -0.02 % | $ 16.3 B | USA |
 |
BioLife Solutions
BLFS
|
5 M | $ 19.27 | -1.23 % | $ 888 M | USA |
 |
AtriCure
ATRC
|
61.9 M | $ 29.19 | 0.41 % | $ 1.39 B | USA |
 |
electroCore
ECOR
|
6.61 M | $ 7.04 | 3.53 % | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
147 K | $ 9.75 | 3.72 % | $ 23.7 M | USA |
 |
Glaukos Corporation
GKOS
|
70.5 M | $ 116.69 | 3.48 % | $ 5.65 B | USA |
 |
Haemonetics Corporation
HAE
|
921 M | $ 58.46 | 2.87 % | $ 2.94 B | USA |
 |
Harvard Bioscience
HBIO
|
35.9 M | $ 5.53 | 6.35 % | $ 245 M | USA |
 |
ICU Medical
ICUI
|
1.27 B | $ 122.99 | -0.26 % | $ 3.03 B | USA |
 |
InfuSystem Holdings
INFU
|
33.2 M | $ 9.43 | 1.51 % | $ 195 M | USA |
 |
iRhythm Technologies
IRTC
|
65 M | $ 117.22 | 0.36 % | $ 3.75 B | USA |
 |
Isoray
ISR
|
1.62 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
132 M | $ 452.58 | 0.11 % | $ 162 B | USA |
 |
Repro Med Systems
KRMD
|
78.7 K | $ 4.26 | -1.39 % | $ 197 M | USA |
 |
LeMaitre Vascular
LMAT
|
169 M | $ 109.16 | 0.62 % | $ 2.47 B | USA |
 |
Masimo Corporation
MASI
|
728 M | $ 178.49 | -0.06 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
569 K | $ 2.36 | -1.67 % | $ 108 M |  Israel |
 |
Milestone Scientific
MLSS
|
27.3 K | $ 0.29 | 1.9 % | $ 23.8 M | USA |
 |
Merit Medical Systems
MMSI
|
734 M | $ 67.81 | 0.16 % | $ 4.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.45 B | $ 25.81 | - | $ 4.34 B | USA |
 |
Predictive Oncology
POAI
|
904 K | - | - | $ 31.1 M | USA |
 |
Pro-Dex
PDEX
|
15.4 M | $ 48.53 | -6.08 % | $ 160 M | USA |
 |
Pulse Biosciences
PLSE
|
5.96 M | $ 22.94 | -0.26 % | $ 1.55 B | USA |
 |
ResMed
RMD
|
765 M | $ 224.93 | 0.37 % | $ 32.9 B | USA |
 |
NeuroMetrix
NURO
|
92.5 K | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
32.5 M | $ 20.96 | 3.71 % | $ 1.04 B | USA |
 |
STERIS plc
STE
|
1.92 B | $ 219.97 | 0.58 % | $ 21.7 B | USA |
 |
Stereotaxis
STXS
|
4.79 M | $ 1.88 | -0.53 % | $ 171 M | USA |
 |
Teleflex Incorporated
TFX
|
2.54 B | $ 115.04 | -2.35 % | $ 5.13 B | USA |
 |
Utah Medical Products
UTMD
|
396 K | $ 62.93 | -0.3 % | $ 204 M | USA |
 |
West Pharmaceutical Services
WST
|
203 M | $ 256.85 | 0.8 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.02 B | $ 11.64 | 0.09 % | $ 2.32 B | USA |
 |
AngioDynamics
ANGO
|
5.8 M | $ 9.84 | -4.56 % | $ 402 M | USA |
 |
Becton, Dickinson and Company
BDX
|
17.6 B | $ 155.32 | 0.52 % | $ 44.7 B | USA |
 |
Nephros
NEPH
|
1.39 M | $ 2.86 | -0.35 % | $ 29.7 M | USA |
 |
OraSure Technologies
OSUR
|
100 K | $ 3.08 | - | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
510 M | $ 116.95 | -0.7 % | $ 6.52 M | USA |